IMPACT BIOMEDICAL INC.

Impact Biomedical Inc. (IBO) shows no cyber incidents or red-flag SEC filings in our 90-day monitoring window, suggesting operational stability in the recent period. However, absence of events in a short timeframe does not eliminate underlying risks—the company's financing structure, shareholder dilution trajectory, and longer-term filing patterns require deeper analysis. The full $49 Report extends coverage to 12 months of activity, adds a proprietary dilution risk score, contextualizes all 8-K filings, and flags AI-detected risk signals across the complete filing history. The full $49 Report adds dilution risk scoring, 12-month 8-K context, financing trajectory analysis, and AI-detected red flags across the entire public record.